Echocardiographic predictors of left ventricular outflow tract obstruction and systolic anterior motion of the mitral valve after mitral valve reconstruction for myxomatous valve disease  by Maslow, Andrew D. & Levine, Robert A.
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~ " ]  Aprotinln Prevents Fibrin Formation in Cardiac 
Surfer,,' 
Jeanne L Bennett, Lesley Doyle, Jsnis Shaw, Barry R. H. Dcr~n, Daniel J. 
M. Keenan, Jassica T. Douglas. Vascular Biology Group, Uni;'.'rsily Dept. of 
Anaesthesia nd Cardiothoracic Unit, Royal Infirmary, Manchester, England 
Aprotinin has been shown to significantly reduce bleeding following cardiac 
surgery, however it is unclear what is the most appropriate dosage, what risks 
are involved and finally what underlying physiological mechanism controls 
the reduction in bleeding? The effect of different concentrations of Aprotlnln 
(095 x 106 - 4.45 x 106 KU, Trasyo", Bayer) w be assessed in 4 
groups undergoing coronary artery bypass graft surgery (CABG) in relation 
to a control group of patients who will only receive beparin (each group, 
n = 40). Measurements of bleeding; platslet aggregation to collagen and 
ristocetin; t.PA, u-PA and PAl-l; soluble fibrin and fibrin speciflo degradation 
products (D-dlmer), (AGEN Biomedical, Brisbane, Australia) and factor X1 la 
will be obtained a) post induction of anaesthesia, b) following aprotinin, 
c) following heparin administration, d) during cardiopulmonary bypass, e) 
immediately following bypass, f) 2 hours g) 6 hours, h) day 1 and i) dw 
5 postoperatively. Preliminary results from 32 patients show that Aprctinin 
reduces circulating levels of soluble tibrin following CABG when compared to 
the control group (1.85/~g/ml vs 0.53/~g/ml, median) p < 0.001 at all doses 
of ,^.protinin. Aprotihin modifies the increase in XDP shown in the control 
group at the end of bypass (290 ng/ml vs 48 ng/ml) p < 0,05 and reduces 
cross-linked egradation products on day 5 postoperatively (538 ~g/ml vs 
2116 ng/ml) p < 0.001 with an apparent dose related effect. These preliminary 
findings suggest that the mode of action of a~rotinin in reducing blood loss 
following CABG may be due in part to ths prevention of fibrin formation with a 
resultant decrease in fibrin degradation products thus forming a more stable 
hasmostatio plug with reduced bleeding foflowing surgery. Our preliminary 
findings suggests higher dosages of Aprotinin have beneficial h~mostatic 
effects which should result in a more widespread use in cardiac surgery thus 
reducing the amount of blood and blood products used with a decrease in 
attendant risks and costs. (British Heart Foundation Grant PG/94099). 
~ Echocardlographlc Predictors of  Left Ventrlcular 
Outf low Tract Obctmctlon and Systolic Anterior 
Motion of  the Mltral Valve After Bltral Valve 
Reconstruction for Myxomatou~ Valve Dlse~;se 
Andrew D. Maslow, Robert A, Levine. Beth israel Hosp,,c~ and 
Massachusetts General Hospital, Boston, MA 
Recent studies have described left ventrlcular outflow tract obstruction/systolic 
anterior motion (LVOTO/SAM) after mitrel valve reconstruction (MVR) in pa- 
tit=hiS with myxomatous mitral valve disease, but have not explored predictors 
of SAM by transesophageat (TEE) echo prior to MVR. We therefore exam- 
ined 5 consecutive patients who developed SAM after MVR (group 1) and 
an equal number who did not (group 2), In a standard long-axis view, the 
leogths oi the coapted antsdor (ALl and posterior (PL) leaflets (annulus to 
coaptation) and the distance from coaptstion point to ssptum (C-Sept) were 
measured before MVR, during SAM, and when SAM resolved. 
Results: Prior to MVR, group 1 had a significantly smaller AL/PL ratio (p < 
0.05) and C-Sept distance (p < 0,05) compared to group 2. 
Pra MVR LVOTO/SAM No LVOTOISAM 
Group I Group 2 Group 1 Group I Group 2 
AUPL 0.02 (0.15) 1.98 (0.40) ° 1.09 (0.20) 2.02 (0.38) o 3.25 (0.54) 
C-Sept (cm) 2.31 (0.20) 3.16 (0.58)* 1.R,,0 (0.35) 2.32 (0.37)Q 2.g9 (0.49) 
"p < 0.05 vs group 1 before MVR; Op < 0.05 vs group 1 with SAM 
Conclusions: These initial rssuits suggest that a greater contribution of 
the posterior leaflet and a smaller C-Sept distance by TEE before MVR 
mW Indicate an increased risk of LVOTO/$AM after MVR in patients with 
myxomatous valves, Resolution of LVOTO/SAM was associated with shifts 
of the coaptation point away from the LVOT and a greater contribution of 
the anterior leaflet to valve clouurs. This is consistent with the concept hat 
SAM relates to anterior malpesitlon of slack leaflet portions into the LVOT, 
especially if the posterior leaflet is elongated. 
~ Ventficuloartedal Coupling and the "Physiology" of  
He~onstructive Surgery for Left Ventricular 
Aneurysm 
Fable Fantint, Madsa Ot Donate, G i~ Badetta, Ann8 Toso 1 
Micbel Sabalk~ 1, Vlncant Do~. Caro~ Un/t Un/ven~/ty of Romnce,/tsty: 
~ Csr0rotfWa~ C, ena~ of Moneco, Monaca 
To Inve~igme coUl l~ betw~m the he~t taxi ~ =~mm In ~eft ven- 
trlc~ (LV) an~ and ~ m o ~  ~.~tm" reco~ mm~ery. 
vantion (A), after 1 week (B), and after 1 year (C). The slope of arterial 
end-systolic pressure-stroke volume (arterial elastanca -As) was compared 
to the hemodynamic data calculated by me~_n of frame-by-frame analysis of 
ventrioufographles and high fidelity pressure tracings, recorded during atrial 
pacing ($1.$1 600 msec). 
EDVI SVl LVEF Emax Ae Ao/Emax 
A 208:1:82 59±18 31 <-12 1.09<-0.73 2.35-~0.88 2.68±1.1 
B 141 ±39" 60±13 46<-13" 1.63=1:0.82" 1.734-0.40" 1.34.+.0.84" 
C 139<-44" 59<-16 43<-10 °§ 1.60<-0.92 2.07±1.1" 1.48±0.04" 
*p .(: 0.05 vs A; gp < 0.05 C vs B; EDVI - end-diastolic volume index; SVI - stroke index; 
EF - ejection fraction; Emax - maximal pressure/volume ratio. 
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Ae/Emx showed an Inverse hyperbolic correlation with LVEF (left graph) 
and a direct linear corrslat[o,~ with EDVI (right graph). The postoperatory 
increase in Emax was related to the EDVI decrease (R = -0.58; p < 0.02), 
Percent changes in LVEF (A vs B) correlated to those in Ae (R ,, -0.575; p < 
0,025), Emax (R = 0.53; p < 0,042) and Ae/Emax (It ,, -0.83, p < 0.0001); 
early results were confirmed after 1 year {A vs C and B vs C). 
Conclusion: ventriculoartarial coupling is the physiological link among the 
structural changes caused by LV aneurysmectomy, LV pump function and 
postoparatory cardioclrculatory equilibrium. 
~ ' ~  Intermittent lechemla Prior Reveralble to Prolonged 
lachemla Protects Canine Myocyte Contractil ity 
Douglas Baldwin, Y. Chandrsshskhar, Herbert Ward, Dao~heng Liu, 
(ndar Anand. VA Medical Center and Univ. of Minnesota, Minneapolis, MN 
We hypothesized that contractility and calcium dynamics would be protected 
in myocytes from dogs (n : 6) treatod with regional intermittent ischemia 
prior to global ischemia. After four 3 minute LAD occlusions followed by 
repertusion, the heart was made ischemic with aortic cross-clamping for 20 
minutes on cardiopufmonary b pass then roporfused for 60 minutes. Isolated 
single myocytss from LAD and remote regions were studied for differences 
in contracUfity (percent shortening, using a video edge detection system) and 
intracallular calcium transients (delta [Call, using Furs 2 AM). LAD region 
myocytes showed a dose dependent increase in contractility (similar to our 
controls, data not shown) with increasing extracellular calcium (1-6 mM) 
while remote region myocytss failed to respond (p < 0.01, ANOVA). Both 
LAD and remote cells showed normal and equal increases in [Call with 
increasing extracellular calcium concentrations (p < 0,05). 
a LAD I~ Remote 2°'T I ~oo~ 
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Sxtrcellular Calcium Extracol~lar Caldum 
These dala suggest hat prolonged reversible Ischemia decreases myofil- 
ament calcium sensitivity and that Intermittent pmischemla protests myofila. 
ment relmonse to calcimn, 
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